Eli Lilly and Company · 10 hours ago
Associate VP - Health Economics and Outcomes Research (HEOR) - Global CMH
US, Indianapolis IN
Full-time
Onsite
Director/Executive
$243K/yr - $356K/yr
10+ years expEli Lilly and Company is a global healthcare leader headquartered in Indianapolis, Indiana. They are seeking an exceptional leader to manage their Real-World Evidence function for Cardiometabolic Health, overseeing a team and shaping the RWE strategy to support evidence generation for their therapies in obesity, diabetes, and cardiovascular disease.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Provide strategic oversight of the cardiometabolic RWE portfolio, aligning evidence generation with business objectives
Work collaboratively with cross-functional partners including Medical Affairs, Commercial, Patient/Regulatory Affairs (PRA), and Development teams to identify evidence gaps and establish project priorities
Oversee the design, execution, and delivery of a diverse portfolio of RWE studies across cardiovascular disease, diabetes, obesity, and metabolic disorders
Ensure all RWE projects are delivered on time, within budget, and to the highest scientific standards
Execute publication and communication strategies that maximize scientific impact and visibility of RWE findings
Recruit, develop, and manage a high-performing team of RWE scientists with diverse expertise in epidemiology, biostatistics, health economics, and outcomes research
Foster a culture of scientific excellence, innovation, and collaboration within the RWE team
Provide mentorship and career development opportunities for team members
Build team capabilities in emerging RWE methodologies and data sources
Forge strategic partnerships with leading academic institutions, research organizations, and healthcare data companies to access novel data sets and advanced analytic capabilities
Identify and evaluate external collaborators with unique data assets (e.g., EHR systems, claims databases, registries, wearable device data)
Negotiate and manage collaboration agreements that advance Lilly's RWE objectives
Represent Lilly in external scientific forums and maintain relationships with key opinion leaders in real-world evidence
Generate real-world evidence to support regulatory submissions and post-approval requirements, working closely with development teams
Identify new therapeutic uses and potential New Indication for a Licensed Product (NILEX) opportunities through analysis of real-world data patterns
Demonstrate the clinical and economic value of Lilly's cardiometabolic medicines through rigorous comparative effectiveness research, health outcomes studies, and health economic analyses
Translate RWE findings into actionable insights for commercial strategy and medical affairs initiatives
Ensure all RWE studies adhere to best practices in study design, analysis, and reporting (ISPOR guidelines, STROBE, etc.)
Develop and implement innovative methodologies for causal inference, comparative effectiveness, and patient outcomes assessment
Drive scientific disclosure through high-impact publications, presentations at major conferences, and engagement with the scientific community
Stay current with evolving regulatory guidance on RWE and ensure compliance across all studies
Qualification
Required
PhD, PharmD, MD, or equivalent advanced degree in epidemiology, health services research, outcomes research, biostatistics, or related field
Minimum 10 years of experience in real-world evidence, outcomes research, or epidemiology within the pharmaceutical or biotech industry
Preferred
Proven track record of leading RWE teams and delivering high-quality evidence generation programs
Deep expertise in real-world data sources (claims, EHR, registries) and advanced analytic methods for observational studies
Strong understanding of cardiometabolic diseases and their treatment landscape
Demonstrated success in establishing and managing external research partnerships
Experience supporting regulatory submissions with RWE (FDA, EMA)
Excellent scientific writing and communication skills with multiple peer-reviewed publications
Strong leadership, collaboration, and influence skills across matrixed organizations
Experience with novel data sources including wearables, patient-generated data, and digital health platforms
Knowledge of health economics and value demonstration methodologies (HEOR, budget impact, cost-effectiveness)
Familiarity with FDA guidance on RWE for regulatory decision-making
Experience in cardiometabolic therapeutic categories including incretins, amylins, insulins, and lipid-lowering medications
Track record of identifying and advancing NILEX opportunities through RWE
Benefits
Company bonus
401(k)
Pension
Vacation benefits
Medical, dental, vision and prescription drug benefits
Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts)
Life insurance and death benefits
Certain time off and leave of absence benefits
Well-being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities)
Company
Eli Lilly and Company
We're a medicine company turning science into healing to make life better for people around the world.
10001+ employees
H1B Sponsorship
Eli Lilly and Company has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (514)
2024 (236)
2023 (167)
2022 (133)
2021 (57)
2020 (52)
Funding
Current Stage
Public CompanyTotal Funding
$6.5M2024-02-12Post Ipo Debt· $6.5M
1978-01-13IPO
Leadership Team
David Ricks
Chair, CEO
Lucas Montarce
Executive Vice President and Chief Financial Officer
Recent News
The Motley Fool
2026-01-25
2026-01-24
2026-01-23
Company data provided by crunchbase